Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consensus on Human Epidermal Growth Factor Receptor 2 Overexpression Testing in Pan-Tumor.

Cancer innovation·2026
Same author

Targeting polyamine metabolism and ferroptosis enhances the efficacy of KRAS-targeted therapy depending on KEAP1 status.

Nature communications·2025
Same author

Functional Characterization and a Real-World Clinical Laboratory Pilot of the Foundation for the National Institutes of Health Circulating Tumor DNA Quality Control Materials.

JCO precision oncology·2025
Same author

Development and Prospective Validation of a Cell-free DNA-Based Model for the Early Detection of Pancreatic Cancer.

Cancer discovery·2025
Same author

Characterization of the extrinsic and intrinsic signatures and therapeutic vulnerability of small cell lung cancers.

Signal transduction and targeted therapy·2025
Same author

A Case of Measles Virus-caused Subacute Sclerosing Panencephalitis Diagnosed by Molecular and Clinical Analysis.

Open forum infectious diseases·2025

Related Experiment Video

Updated: Jun 19, 2026

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
10:33

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts

Published on: April 29, 2014

11.1K

Molecular landscape and multi-omic measurements of heterogeneity in fetal adenocarcinoma of the lung.

Li Sun1, Wei Guo2,3, Lei Guo1

  • 1Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.

NPJ Precision Oncology
|June 3, 2024
PubMed
Summary
This summary is machine-generated.

Fetal adenocarcinoma of the lung (FLAC) subtypes show distinct multi-omics profiles and intratumor heterogeneity (ITH). Lower genetic ITH correlates with poorer survival, while higher methylation ITH in high-grade FLAC indicates shorter survival.

More Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.3K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.1K

Related Experiment Videos

Last Updated: Jun 19, 2026

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
10:33

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts

Published on: April 29, 2014

11.1K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.3K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.1K

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Fetal adenocarcinoma of the lung (FLAC) is a rare lung adenocarcinoma subtype.
  • Existing studies on FLAC are limited, primarily small case series.
  • A comprehensive multi-omics investigation of FLAC is lacking.

Purpose of the Study:

  • To characterize the multi-omics landscape of FLAC.
  • To compare the molecular profiles of high-grade (H-FLAC) and low-grade (L-FLAC) subtypes.
  • To investigate the relationship between multi-layer intratumor heterogeneity (ITH) and patient prognosis.

Main Methods:

  • Multi-regional sampling was performed on 20 FLAC cases.
  • Multi-omics profiles were generated and compared between H-FLAC and L-FLAC.
  • The association between different types of ITH (genetic, methylation) and survival outcomes was analyzed.

Main Results:

  • Significant differences in multi-omics profiles were observed between H-FLAC and L-FLAC.
  • Distinct relationships between multi-layer ITH were found for the two subtypes.
  • Lower genetic ITH was linked to worse recurrence-free and overall survival.
  • Higher methylation ITH in H-FLAC was associated with shorter survival.

Conclusions:

  • FLAC exhibits complex genetic and transcriptional heterogeneity.
  • Different types of ITH have distinct prognostic implications in FLAC.
  • Understanding ITH is crucial for predicting FLAC patient outcomes.